What does CUSIP 142038108 represent in this 13F holders report?

CUSIP 142038108 is the security identifier for CRBU - Caribou Biosciences, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held CRBU - Caribou Biosciences, Inc. - Common Stock in Q2 2023?

117 institutional investors reported CRBU - Caribou Biosciences, Inc. - Common Stock for Q2 2023. Use the holders table for investor-level position and value details.

Caribou Biosciences, Inc. - Common Stock (CRBU)

CUSIP: 142038108

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock
Shares outstanding: 92,189,700
Total 13F shares: 43,715,651
Share change: -1,235,975
Total reported value: $185,309,815
Put/Call ratio: 82%
Price per share: $4.25
Number of holders: 117
Value change: -$6,639,016
Number of buys: 60
Number of sells: 52

Quarterly Holders Quick Answers

What is CUSIP 142038108?
CUSIP 142038108 identifies CRBU - Caribou Biosciences, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 142038108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CRBU - Caribou Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PFM Health Sciences, LP	13F	Company	5.4%	5,012,118	$26,614,347	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5.2%	4,754,563	$25,246,730	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	3.6%	3,355,292	$17,816,601	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	3%	2,758,600	$14,648,166	—	31 Mar 2023	13F
Rokos Capital Management LLP	13F	Company	3%	2,748,139	$14,086,136	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	2.9%	2,632,385	$13,977,965	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2.8%	2,606,061	$13,838,183	—	31 Mar 2023	13F
Elmwood Wealth Management, Inc.	13F	Company	2.6%	2,364,240	$12,554,115	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	2.2%	2,066,176	$10,971,395	—	31 Mar 2023	13F
FMR LLC	3/4/5 13F	Other* · Company	1.6% from 13F	3,323,284	$9,836,921	—	27 Jul 2021	3/4/5 13F
MORGAN STANLEY	13F	Company	1.4%	1,249,248	$6,633,507	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	1,069,624	$5,679,703	—	31 Mar 2023	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	1.1%	1,054,645	$5,600,164	—	31 Mar 2023	13F
FIL Ltd	13F	Company	0.93%	860,666	$4,570,136	—	31 Mar 2023	13F
Assenagon Asset Management S.A.	13F	Company	0.91%	843,025	$4,476,463	—	31 Mar 2023	13F
MAVERICK CAPITAL LTD	13F	Company	0.71%	652,542	$3,464,998	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.65%	602,978	$3,202,000	—	31 Mar 2023	13F
Tekla Capital Management LLC	13F	Company	0.62%	567,147	$3,011,551	—	31 Mar 2023	13F
Sloan Kettering Cancer Center Memorial	13F	Individual	0.59%	544,196	$2,889,681	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.57%	529,005	$2,809,018	—	31 Mar 2023	13F
72 Investment Holdings, LLC	13F	Company	0.51%	474,067	$2,517,296	—	31 Mar 2023	13F
INTERNATIONAL BIOTECHNOLOGY TRUST PLC	13F	Company	0.5%	457,892	$2,426,828	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.45%	410,449	$2,179,484	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.35%	325,015	$1,726,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.34%	313,769	$1,666,114	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.32%	292,964	$1,556,000	—	31 Mar 2023	13F
Point72 Asset Management, L.P.	13F	Company	0.31%	289,739	$1,538,514	—	31 Mar 2023	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.31%	287,033	$1,524,145	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.31%	282,850	$1,501,934	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.25%	233,783	$1,241,388	—	31 Mar 2023	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.24%	223,237	$1,185,389	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.23%	213,283	$1,132,532	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.21%	195,695	$1,039,140	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.2%	185,994	$987,628	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.15%	139,755	$742,099	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.14%	128,931	$684,624	—	31 Mar 2023	13F
Granahan Investment Management, LLC	13F	Company	0.13%	121,650	$645,962	—	31 Mar 2023	13F
Swiss National Bank	13F	Company	0.11%	105,300	$559,143	—	31 Mar 2023	13F
Artal Group S.A.	13F	Company	0.11%	105,347	$559,000	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.11%	101,192	$537,330	—	31 Mar 2023	13F
Bruce & Co., Inc.	13F	Company	0.11%	100,000	$531,000	—	31 Mar 2023	13F
Of The University Of California Regents	13F	Individual	0.1%	90,652	$481,362	—	31 Mar 2023	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.1%	89,224	$473,779	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.09%	87,473	$464,000	—	31 Mar 2023	13F
Nelson Capital Management, LLC	13F	Company	0.09%	85,020	$451,457	—	31 Mar 2023	13F
Green Alpha Advisors, LLC	13F	Company	0.09%	84,467	$448,520	—	31 Mar 2023	13F
NORGES BANK	13F	Company	0.09%	82,700	$439,137	—	31 Mar 2023	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.09%	79,150	$420,287	—	31 Mar 2023	13F
S.c.a. Candriam	13F	Individual	0.09%	85,556	$418,153	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.08%	77,700	$413,000	—	31 Mar 2023	13F

Institutional Holders of Caribou Biosciences, Inc. - Common Stock (CRBU) as of Q2 2023

As of 30 Jun 2023, Caribou Biosciences, Inc. - Common Stock (CRBU) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,715,651 shares. The largest 10 holders included PFM Health Sciences, LP, BlackRock Inc., Avidity Partners Management LP, BANK OF AMERICA CORP /DE/, Rokos Capital Management LLP, VANGUARD GROUP INC, Elmwood Wealth Management, Inc., PICTET ASSET MANAGEMENT SA, FMR LLC, and ALKEON CAPITAL MANAGEMENT LLC. This page lists 117 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

126

Q2 2023 holders

117

Holder diff

-9

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.